LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and AI solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13-14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will bring together students, faculty, and professionals from systems engineering and healthcare fields to explore practical applications of AI and automation.
Representing LataMed AI will be Dr. Kevin Rodan Levy, CEO, and Carlos Pena, CFO. Their presentation will address the evolving role of AI in healthcare, systems engineering, digital infrastructure, and professional decision-making. The company intends to discuss how AI-supported tools can assist healthcare professionals with medical-data evaluation, clinical workflows, and operational efficiency, while emphasizing the importance of maintaining qualified professional oversight.
According to Dr. Levy, “Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering. Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America.”
The conference will also cover topics such as integrating AI into existing systems, responsible data use, privacy and information security, operational risk management, and practical considerations for deploying technology in healthcare settings. LataMed AI will also discuss the development of its CardioAI, PulmoAI, and NeuroAI platforms, designed to assist in evaluating cardiovascular, pulmonary, and neurological health information.
LataMed AI believes that engaging with universities is crucial for raising awareness of emerging healthcare technologies and fostering responsible discussions about AI. This participation aligns with its broader strategy of supporting education and professional collaboration to drive digital healthcare infrastructure in the region. The company plans to continue seeking opportunities to participate in academic and technology forums.
This announcement is based on a press release from LataMed AI. For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
